Male gender ( p = 0.082, HR 3.97, 95% CI 0.84–18.90) and voriconazole use ( p = 0.659, HR 1.35, 95% CI 0.35–5.20) were associated with an increased risk of cSCC but did not reach statistical significance.
← all excerpts
The incidence of cutaneous squamous cell carcinoma in patients receiving voriconazole therapy for chronic pulmonary aspergillosis.
1
—
—